TY - JOUR
T1 - Survivorship
T2 - Cognitive function, Version 1.2014; Clinical practice guidelines in oncology
AU - Denlinger, Crystal S.
AU - Ligibel, Jennifer A.
AU - Are, Madhuri
AU - Baker, K. Scott
AU - Demark-Wahnefried, Wendy
AU - Friedman, Debra L.
AU - Goldman, Mindy
AU - Jones, Lee
AU - King, Allison
AU - Ku, Grace H.
AU - Kvale, Elizabeth
AU - Langbaum, Terry S.
AU - Leonardi-Warren, Kristin
AU - McCabe, Mary S.
AU - Melisko, Michelle
AU - Montoya, Jose G.
AU - Mooney, Kathi
AU - Morgan, Mary Ann
AU - Moslehi, Javid J.
AU - O'Connor, Tracey
AU - Overholser, Linda
AU - Paskett, Electra D.
AU - Raza, Muhammad
AU - Syrjala, Karen L.
AU - Urba, Susan G.
AU - Wakabayashi, Mark T.
AU - Zee, Phyllis
AU - McMillian, Nicole R.
AU - Freedman-Cass, Deborah A.
PY - 2014/7/1
Y1 - 2014/7/1
N2 - Cognitive impairment is a common complaint among cancer survivors and may be a consequence of the tumors themselves or direct effects of cancer-related treatment (eg, chemotherapy, endocrine therapy, radiation). For some survivors, symptoms persist over the long term and, when more severe, can impact quality of life and function. This section of the NCCN Guidelines for Survivorship provides assessment, evaluation, and management recommendations for cognitive dysfunction in survivors. Nonpharmacologic interventions (eg, instruction in coping strategies; management of distress, pain, sleep disturbances, and fatigue; occupational therapy) are recommended, with pharmacologic interventions as a last line of therapy in survivors for whom other interventions have been insufficient.
AB - Cognitive impairment is a common complaint among cancer survivors and may be a consequence of the tumors themselves or direct effects of cancer-related treatment (eg, chemotherapy, endocrine therapy, radiation). For some survivors, symptoms persist over the long term and, when more severe, can impact quality of life and function. This section of the NCCN Guidelines for Survivorship provides assessment, evaluation, and management recommendations for cognitive dysfunction in survivors. Nonpharmacologic interventions (eg, instruction in coping strategies; management of distress, pain, sleep disturbances, and fatigue; occupational therapy) are recommended, with pharmacologic interventions as a last line of therapy in survivors for whom other interventions have been insufficient.
UR - http://www.scopus.com/inward/record.url?scp=84903965184&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84903965184&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2014.0094
DO - 10.6004/jnccn.2014.0094
M3 - Article
C2 - 24994918
AN - SCOPUS:84903965184
SN - 1540-1405
VL - 12
SP - 976
EP - 986
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 7
ER -